Targeting epigenetic modifications in Parkinson's disease therapy
Medicinal Research Reviews · 2023-09 · 43 (5) · 1748-1777
DOI: 10.1002/med.21962 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 29.04.2023. Verfasst von Dan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy and Joint Research Institution of Altitude Health and National Clinica…. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 227 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Parkinson's disease (PD) is a multifactorial disease due to a complex interplay between genetic and epigenetic factors. Recent efforts shed new light on the epigenetic mechanisms involved in regulating pathways related to the development of PD, including DNA methylation, posttranslational modifications of histones, and the presence of microRNA (miRNA or miR). Epigenetic regulators are potential therapeutic targets for neurodegenerative disorders. In the review, we aim to summarize mechanisms of epigenetic regulation in PD, and describe how the DNA methyltransferases, histone deacetylases, and histone acetyltransferases that mediate the key processes of PD are attractive therapeutic targets. We discuss the use of inhibitors and/or activators of these regulators in PD models or patients, and how these small molecule epigenetic modulators elicit neuroprotective effects. Further more, given the importance of miRNAs in PD, their contributions to the underlying mechanisms of PD will be discussed as well, together with miRNA‐based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy and Joint Research Institution of Altitude Health and National Clinical Research Center for Geriatrics,West China Hospital, Sichuan Universi…
- Targeted Tracer Research and Development Laboratory, Institute of Respiratory Health, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Liang Ouyang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, D., Zhang, J., Wang, Y., Wang, G., Tang, P., Liu, Y., Zhang, Y., & Ouyang, L. (2023). Targeting epigenetic modifications in Parkinson's disease therapy. Medicinal Research Reviews, 43(5), 1748-1777. https://doi.org/10.1002/med.21962
Vancouver
Zhang D, Zhang J, Wang Y, Wang G, Tang P, Liu Y, et al. Targeting epigenetic modifications in Parkinson's disease therapy. Medicinal Research Reviews. 2023;43(5):1748-1777. doi:10.1002/med.21962
BibTeX
@article{Zhang2023,
author = {Zhang, Dan and Zhang, Jifa and Wang, Yuxi and Wang, Guan and Tang, Pan and Liu, Yun and Zhang, Yiwen and Ouyang, Liang},
title = {Targeting epigenetic modifications in Parkinson's disease therapy},
journal = {Medicinal Research Reviews},
year = {2023},
volume = {43},
number = {5},
pages = {1748--1777},
doi = {10.1002/med.21962}
}
EUVIMED